| Focus article |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Pain beliefs, coping, and adjustment to chronic pain: Let's focus more on the negative
Pain beliefs and coping are believed to be important determinants of adjustment to chronic pain. The majority of the studies in this area have focused on the potential benefits of adaptive pain coping...
|
Michael E. Geisser,
Michael E. Robinson,
Joseph L. Riley
|
161-168
|
|
| Commentaries |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Pain beliefs and coping attempts: Conceptual model building
A reduction of maladaptive responses to pain is crucial in adjustment to chronic painful states. However, previous research has also demonstrated that adjustment to pain is predicted by interactions b...
|
Beverly E. Thorn,
Martha Anne Rich,
Jennifer L. Boothby
|
169-171
|
|
|
|
Coping with pain: What works, under what circumstances, and in what ways?
Geissen Robinson, and Riley present a stimulating conceptual model of coping with chronic pain in which the authors argue that maladaptive beliefs and coping are primary determinants of adjustment and...
|
Jennifer A. Haythornthwaite,
Leslie J. Heinberg
|
172-175
|
|
|
|
Catastrophizing research: Avoiding conceptual errors and maintaining a balanced perspective
This Commentary addresses some common conceptual errors and methodological issues raised by the Focus article by Geisser, Robinson, and Riley. One conceptual error, the problem of confounding coping w...
|
Francis J. Keefe,
John C. Lefebvre,
Suzanne J. Smith
|
176-180
|
|
| Reply |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Reply to the commentaries
|
Michael E. Geisser,
Michael E. Robinson,
Joseph L. Riley
|
181-182
|
|
| Focus article |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The fallacy of using 50% pain relief as the standard for satisfactory pain treatment outcome
Chronic pain treatment outcomes are difficult to standardize. Pain levels and improvement in pain often do not correlate with functional ability, need for medication, or suffering behaviors. The 50% t...
|
Joel L. Seres
|
183-188
|
|
| Commentaries |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The fallacy of using a solitary outcome measure as the standard for satisfactory pain treatment outcome
‘Success” connotes that a goal has been achieved. For many pain therapies, pain reduction is selected as the goal, and 50% reduction of pain intensity is selected frequently as the threshold for decla...
|
Kenneth A. Follett
|
189-191
|
|
|
|
Seres' fallacies
Accurate determination of treatment outcomes is critical in the development of new therapies and the evaluation of existing treatments. Valid measures and meaningful statistical inferences are require...
|
John D. Loeser
|
192-194
|
|
|
|
The glass is half full
The “modern” criterion of 50% pain relief has long-standing precedents in the “ancient” literature. We agree that other measures of outcome, which reflect pain relief indirectly, are important, and ac...
|
Richard B. North
|
195-197
|
|
| Reply |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Measuring the impact of pain
|
Joel L. Seres
|
198-199
|
|
| Focus article |
| |
Article Title |
Author(s) |
Pages |
|
|
|
New perspectives in our use of opioids
Some opioids in common use (eg, methadone) differ from others (eg, morphine) in beingN-methyl-d-aspartic acid receptor antagonists and inhibitors of monoamine transmitter reuptake. The nonopioid recep...
|
John S. Morley
|
200-205
|
|
| Commentaries |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The Mu3 opiate receptor subtype
The mu3 opiate receptor subtype has been characterized by various binding assays as opiate alkaloid selective (eg, morphine) and opioid peptide (eg, methionine enkephalin) insensitive. The binding is ...
|
George B. Stefano
|
206-209
|
|
|
|
Old dogs, new tricks
Many hyperalgesic states and the development of tolerance to morphine converge at the cellular level through the activation of the N-methyl-D-aspartic acid (NMDA) receptor and common signal transducti...
|
Charles E. Inturrisi
|
210-212
|
|
|
|
Anticancer effects of therapeutic opioids
In addition to their use in pain management in terminal cancer patients, therapeutic opioids have been found to be potent inducers of apoptosis in several types of human cancer cells, resulting in the...
|
Rhoda Maneckjee
|
213-215
|
|
|
|
Author index
|
|
216
|
|
|
|
Subject index
|
|
217-221
|
|
